Background: Differentiating follicular thyroid carcinoma (FTC) from follicular adenoma (FA) is challenging due to their histological similarities. This systematic review and meta-analysis aimed to assess the difference in Ki-67 expression between FTC and FA to evaluate its diagnostic utility.
Methods: We conducted a comprehensive search of PubMed, Embase, Scopus, and Web of Science databases for studies reporting Ki-67 expression in FTC and FA. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. A random-effects model was applied to calculate the pooled mean difference of the Ki-67 index, with heterogeneity assessed by the Cochran Q and I-squared tests. Meta-regression was used to explore sources of heterogeneity, and publication bias was evaluated using Egger's test, Begg's test, and funnel plot.
Results: The meta-analysis revealed a pooled mean difference in Ki-67 expression between FTC and FA of 1.13 (0.63-1.63), indicating a significant difference. In addition, the difference in the Ki-67 index between minimally invasive follicular carcinoma and FA was 0.56 (0.12-1.00), which was also statistically significant. The heterogeneity among included studies was due to variations in Ki-67 index calculation methods. The reviewed studies demonstrated low sensitivity but high specificity of Ki-67 for differentiating FTC vs. FA, although diagnostic cut-offs were inconsistent.
Conclusions: This study demonstrates a significant difference in Ki-67 expression between FTC and FA, supporting its potential role as a diagnostic marker. Further research is required to establish standardized diagnostic cut-offs and evaluate Ki-67's sensitivity and specificity in clinical practice.
背景:区分滤泡性甲状腺癌(FTC)和滤泡性腺瘤(FA)是具有挑战性的,因为它们的组织学相似。本系统综述和荟萃分析旨在评估Ki-67表达在FTC和FA之间的差异,以评估其诊断价值。方法:我们对PubMed, Embase, Scopus和Web of Science数据库进行了全面的检索,以报告FTC和FA中Ki-67表达的研究。纳入研究的质量采用纽卡斯尔-渥太华量表进行评估。采用随机效应模型计算Ki-67指数的汇总均差,采用Cochran Q检验和i²检验评估异质性。meta回归分析异质性来源,发表偏倚评价采用Egger检验、Begg检验和漏斗图。结果:荟萃分析显示,FTC与FA之间Ki-67表达的汇总平均差异为1.13(0.63-1.63),差异具有统计学意义。此外,微创滤泡癌与FA的Ki-67指数差异为0.56(0.12-1.00),差异亦有统计学意义。纳入研究的异质性是由于Ki-67指数计算方法的差异。所回顾的研究表明,Ki-67在鉴别FTC和FA方面敏感性低,但特异性高,尽管诊断截止值不一致。结论:本研究表明Ki-67在FTC和FA之间的表达有显著差异,支持其作为诊断标志物的潜在作用。在临床实践中,需要进一步的研究来建立标准化的诊断临界值,并评估Ki-67的敏感性和特异性。
{"title":"Diagnostic role of Ki-67 expression in distinguishing thyroid follicular carcinoma from follicular adenoma: a systematic review and meta-analysis.","authors":"Rayehe Rahimi, Fakhrieh Kalavari, Yalda Ashoorian, Mohammad Amin Ashoobi, Enayatollah Homaie Rad, Saeid Anvari","doi":"10.1097/MS9.0000000000004503","DOIUrl":"10.1097/MS9.0000000000004503","url":null,"abstract":"<p><strong>Background: </strong>Differentiating follicular thyroid carcinoma (FTC) from follicular adenoma (FA) is challenging due to their histological similarities. This systematic review and meta-analysis aimed to assess the difference in Ki-67 expression between FTC and FA to evaluate its diagnostic utility.</p><p><strong>Methods: </strong>We conducted a comprehensive search of PubMed, Embase, Scopus, and Web of Science databases for studies reporting Ki-67 expression in FTC and FA. The quality of the included studies was assessed using the Newcastle-Ottawa Scale. A random-effects model was applied to calculate the pooled mean difference of the Ki-67 index, with heterogeneity assessed by the Cochran <i>Q</i> and <i>I</i>-squared tests. Meta-regression was used to explore sources of heterogeneity, and publication bias was evaluated using Egger's test, Begg's test, and funnel plot.</p><p><strong>Results: </strong>The meta-analysis revealed a pooled mean difference in Ki-67 expression between FTC and FA of 1.13 (0.63-1.63), indicating a significant difference. In addition, the difference in the Ki-67 index between minimally invasive follicular carcinoma and FA was 0.56 (0.12-1.00), which was also statistically significant. The heterogeneity among included studies was due to variations in Ki-67 index calculation methods. The reviewed studies demonstrated low sensitivity but high specificity of Ki-67 for differentiating FTC vs. FA, although diagnostic cut-offs were inconsistent.</p><p><strong>Conclusions: </strong>This study demonstrates a significant difference in Ki-67 expression between FTC and FA, supporting its potential role as a diagnostic marker. Further research is required to establish standardized diagnostic cut-offs and evaluate Ki-67's sensitivity and specificity in clinical practice.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 2","pages":"1695-1705"},"PeriodicalIF":1.6,"publicationDate":"2026-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-12-11eCollection Date: 2026-02-01DOI: 10.1097/MS9.0000000000004561
Singam Shashank, Rashmikaa Netyam, Chiranjeevee R Saravanan, Nikhil D Kolanu, Nanditha Karra, Harshada S Keluskar, Ziad Helaly, Mohammed H Albitar, Abdullah Sharbek, Seba Albitar, Pugazhendi Inban, Mohammed D M Marsool, Omniat A Hussin
Background: Hybrid coronary revascularization (HCR), a combination of percutaneous coronary intervention and coronary artery bypass grafting (CABG), is an emerging treatment for patients with multivessel coronary artery disease (MVCAD). While traditional CABG is considered the standard, HCR may mitigate issues like saphenous vein graft failure.
Methods: We systematically searched PubMed, Scopus, Web of Science, and Embase until September 2024, targeting randomized controlled trials (RCTs) that evaluated HCR against CABG in MVCAD patients. The quality of included studies was assessed using the ROB2 tool, and data were analyzed using RevMan 5.4. Four RCTs (n = 382) involving 382 participants were analyzed using a random-effects model. Risk of bias was assessed using the ROB2 tool.
Results: Four RCTs (n = 382) met inclusion criteria. At 30 days, there were no statistically significant differences between HCR and CABG in all-cause death (risk ratios [RR] = 1.35, P = 0.74), stroke (RR = 0.99, P = 0.99), myocardial infarction (RR = 1.17, P = 0.74), or blood transfusion (RR = 0.70, P = 0.14), with zero heterogeneity (I2 = 0%). At 1-year follow-up, pooled analyses showed no significant differences in all-cause death (RR = 1.37, P = 0.62) or myocardial infarction (RR = 1.29, P = 0.56), also with consistent homogeneity (I2 = 0%).
Conclusion: HCR demonstrates comparable safety and effectiveness to CABG for MVCAD, with similar rates of key outcomes at both 30 days and 1 year. Further research with larger samples and longer follow-up is recommended to confirm these findings.
背景:混合冠状动脉血管重建术(HCR)是一种经皮冠状动脉介入治疗和冠状动脉旁路移植术(CABG)相结合的治疗方法,是治疗多支冠状动脉疾病(MVCAD)的新方法。虽然传统的冠脉搭桥被认为是标准的,但HCR可以减轻隐静脉移植失败等问题。方法:我们系统地检索PubMed, Scopus, Web of Science和Embase,直到2024年9月,目标是随机对照试验(rct),评估HCR对MVCAD患者CABG的影响。采用ROB2工具评估纳入研究的质量,并使用RevMan 5.4对数据进行分析。采用随机效应模型对4项随机对照试验(n = 382) 382名受试者进行分析。使用ROB2工具评估偏倚风险。结果:4项rct (n = 382)符合纳入标准。30天时,HCR和CABG在全因死亡(风险比[RR] = 1.35, P = 0.74)、卒中(风险比[RR = 0.99, P = 0.99)、心肌梗死(风险比[RR = 1.17, P = 0.74)、输血(风险比[RR = 0.70, P = 0.14)方面无统计学差异,异质性为零(2 = 0%)。在1年的随访中,合并分析显示全因死亡(RR = 1.37, P = 0.62)或心肌梗死(RR = 1.29, P = 0.56)无显著差异,也具有一致的均匀性(I 2 = 0%)。结论:HCR对MVCAD的安全性和有效性与CABG相当,30天和1年的关键结局率相似。建议进行更大样本和更长时间随访的进一步研究,以证实这些发现。
{"title":"Long-term safety and effectiveness of hybrid coronary revascularization compared to conventional revascularization strategies: a systematic review and meta-analysis.","authors":"Singam Shashank, Rashmikaa Netyam, Chiranjeevee R Saravanan, Nikhil D Kolanu, Nanditha Karra, Harshada S Keluskar, Ziad Helaly, Mohammed H Albitar, Abdullah Sharbek, Seba Albitar, Pugazhendi Inban, Mohammed D M Marsool, Omniat A Hussin","doi":"10.1097/MS9.0000000000004561","DOIUrl":"10.1097/MS9.0000000000004561","url":null,"abstract":"<p><strong>Background: </strong>Hybrid coronary revascularization (HCR), a combination of percutaneous coronary intervention and coronary artery bypass grafting (CABG), is an emerging treatment for patients with multivessel coronary artery disease (MVCAD). While traditional CABG is considered the standard, HCR may mitigate issues like saphenous vein graft failure.</p><p><strong>Methods: </strong>We systematically searched PubMed, Scopus, Web of Science, and Embase until September 2024, targeting randomized controlled trials (RCTs) that evaluated HCR against CABG in MVCAD patients. The quality of included studies was assessed using the ROB2 tool, and data were analyzed using RevMan 5.4. Four RCTs (<i>n</i> = 382) involving 382 participants were analyzed using a random-effects model. Risk of bias was assessed using the ROB2 tool.</p><p><strong>Results: </strong>Four RCTs (<i>n</i> = 382) met inclusion criteria. At 30 days, there were no statistically significant differences between HCR and CABG in all-cause death (risk ratios [RR] = 1.35, <i>P</i> = 0.74), stroke (RR = 0.99, <i>P</i> = 0.99), myocardial infarction (RR = 1.17, <i>P</i> = 0.74), or blood transfusion (RR = 0.70, <i>P</i> = 0.14), with zero heterogeneity (<i>I</i> <sup>2</sup> = 0%). At 1-year follow-up, pooled analyses showed no significant differences in all-cause death (RR = 1.37, <i>P</i> = 0.62) or myocardial infarction (RR = 1.29, <i>P</i> = 0.56), also with consistent homogeneity (<i>I</i> <sup>2</sup> = 0%).</p><p><strong>Conclusion: </strong>HCR demonstrates comparable safety and effectiveness to CABG for MVCAD, with similar rates of key outcomes at both 30 days and 1 year. Further research with larger samples and longer follow-up is recommended to confirm these findings.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 2","pages":"1779-1788"},"PeriodicalIF":1.6,"publicationDate":"2026-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12889239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146163672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: In this systematic review, we aimed to evaluate the impacts of probiotics on psychological issues and other symptoms, such as pain and fatigue, in people with fibromyalgia.
Materials and methods: On 19 January 2025, PubMed, Scopus, and Web of Science were searched to identify relevant records. We included studies that evaluated the effects of probiotics, either alone or in combination with other treatments, in individuals diagnosed with fibromyalgia, compared to the placebo or any other form of treatment. The quality of the included studies was assessed using the JBI critical appraisal tools for randomized controlled trials and quasi-experimental studies. We used a qualitative approach for the synthesis in this study.
Results: From a total of 186 articles retrieved in our search, five reports from four studies were included in this review. In total, 209 people with fibromyalgia were included in these studies, with 103 (49.3%) being in the experimental (probiotic) group. All studies fulfilled the majority of the JBI critical appraisal tool criteria. Although some studies reported reductions in anxiety and depression among individuals with fibromyalgia who used probiotics, the findings were not consistent across all studies. Only one study assessed adverse events associated with probiotics compared to placebo, finding no significant differences between the groups in the incidence of at least one adverse event (P > 0.05).
Conclusions: Overall, we cannot make a definitive recommendation for or against the use of probiotics in the treatment of individuals with fibromyalgia, and future studies are needed in this regard.
背景:在这篇系统综述中,我们旨在评估益生菌对纤维肌痛患者的心理问题和其他症状(如疼痛和疲劳)的影响。材料和方法:于2025年1月19日检索PubMed、Scopus和Web of Science以确定相关记录。我们纳入了评估益生菌对纤维肌痛患者的影响的研究,无论是单独使用还是与其他治疗方法联合使用,与安慰剂或任何其他形式的治疗方法相比。采用JBI随机对照试验和准实验研究的关键评价工具对纳入研究的质量进行评估。在本研究中,我们采用了定性方法进行合成。结果:从我们检索到的186篇文章中,来自4项研究的5篇报告被纳入本综述。总共有209名纤维肌痛患者被纳入这些研究,其中103人(49.3%)被纳入实验(益生菌)组。所有的研究都满足了JBI关键评估工具的大部分标准。尽管一些研究报告说,纤维肌痛患者使用益生菌后焦虑和抑郁有所减少,但并不是所有研究的结果都一致。只有一项研究评估了与安慰剂相比益生菌相关的不良事件,发现两组之间至少有一项不良事件的发生率没有显著差异(P < 0.05)。结论:总的来说,我们不能明确推荐或反对使用益生菌治疗纤维肌痛,需要在这方面进行进一步的研究。
{"title":"Effects of probiotics on psychological issues in people with fibromyalgia: a systematic review.","authors":"Amin Nakhostin-Ansari, Negin Khosravipour, Sara Pedram Jafari, Shahdad Ahmadi, Zahra Rabiei, Negar Khorasani, Atousa Janzadeh","doi":"10.1097/MS9.0000000000004726","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004726","url":null,"abstract":"<p><strong>Background: </strong>In this systematic review, we aimed to evaluate the impacts of probiotics on psychological issues and other symptoms, such as pain and fatigue, in people with fibromyalgia.</p><p><strong>Materials and methods: </strong>On 19 January 2025, PubMed, Scopus, and Web of Science were searched to identify relevant records. We included studies that evaluated the effects of probiotics, either alone or in combination with other treatments, in individuals diagnosed with fibromyalgia, compared to the placebo or any other form of treatment. The quality of the included studies was assessed using the JBI critical appraisal tools for randomized controlled trials and quasi-experimental studies. We used a qualitative approach for the synthesis in this study.</p><p><strong>Results: </strong>From a total of 186 articles retrieved in our search, five reports from four studies were included in this review. In total, 209 people with fibromyalgia were included in these studies, with 103 (49.3%) being in the experimental (probiotic) group. All studies fulfilled the majority of the JBI critical appraisal tool criteria. Although some studies reported reductions in anxiety and depression among individuals with fibromyalgia who used probiotics, the findings were not consistent across all studies. Only one study assessed adverse events associated with probiotics compared to placebo, finding no significant differences between the groups in the incidence of at least one adverse event (<i>P</i> > 0.05).</p><p><strong>Conclusions: </strong>Overall, we cannot make a definitive recommendation for or against the use of probiotics in the treatment of individuals with fibromyalgia, and future studies are needed in this regard.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2383-2392"},"PeriodicalIF":1.6,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959785/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-24eCollection Date: 2026-03-01DOI: 10.1097/MS9.0000000000004374
Shreya Singh Beniwal, Yash Satish Caroicar, Kashyapi Patil, Akash Rawat, Adam Sheikh Said, Hari Vorappan Manickavelan, Arusha Desai, Het Tushar Jani, Rafael Everton Assunção Ribeiro da Costa, Alyanna Cabe Cacas, Chandramani Panjabi, Ayush Dwivedi
Periodontitis is a chronic inflammatory disorder that has been recognized as a significant public health concern worldwide. An imbalance between the protective oral microbiota and numerous oral pathogens has been implicated in its pathogenesis. Periodontitis not only impacts an individual's oral health but also has systemic implications. The pathogenesis of periodontitis and these respiratory infections has been shown to be intricately linked. Numerous clinical research and animal studies have highlighted that the oral health of a population is closely related to their systemic health. It has been suggested that the periodontal pockets can act as a reservoir for oral pathogens, which can later migrate into the respiratory tract through aspiration or systemic circulation. This is a narrative review conducted after a wide literature search on databases such as PubMed, Cochrane, and Google Scholar with keywords including "Periodontitis," "Respiratory," "Infections," "Tuberculosis," 'COVID-19', "Pneumonia," "Asthma," and "COPD" published in the last 15 years. The cornerstone of this comprehensive review lies in deciphering the pathogenesis and epidemiology of periodontitis and how these periodontal bacteria contribute to respiratory infections through numerous biological mechanisms, inflammatory pathways, and the potential pathways of infection transmission. We also explore the empirical evidence through research studies supporting the periodontitis-respiratory infections link and also studies with conflicting or inconclusive results. By connecting the dots between this crucial oral-systemic link, we hope to uncover the gaps in the current research and find new avenues for developing cost-effective, targeted, transformative preventive and therapeutic strategies that will not only improve oral health but will also support respiratory health and help reduce the global burden of respiratory infections. Strengthening oral hygiene programs could reduce the burden of respiratory diseases, particularly in elderly and high-risk populations.
{"title":"Periodontitis and respiratory infections - exploring the oral-systemic link.","authors":"Shreya Singh Beniwal, Yash Satish Caroicar, Kashyapi Patil, Akash Rawat, Adam Sheikh Said, Hari Vorappan Manickavelan, Arusha Desai, Het Tushar Jani, Rafael Everton Assunção Ribeiro da Costa, Alyanna Cabe Cacas, Chandramani Panjabi, Ayush Dwivedi","doi":"10.1097/MS9.0000000000004374","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004374","url":null,"abstract":"<p><p>Periodontitis is a chronic inflammatory disorder that has been recognized as a significant public health concern worldwide. An imbalance between the protective oral microbiota and numerous oral pathogens has been implicated in its pathogenesis. Periodontitis not only impacts an individual's oral health but also has systemic implications. The pathogenesis of periodontitis and these respiratory infections has been shown to be intricately linked. Numerous clinical research and animal studies have highlighted that the oral health of a population is closely related to their systemic health. It has been suggested that the periodontal pockets can act as a reservoir for oral pathogens, which can later migrate into the respiratory tract through aspiration or systemic circulation. This is a narrative review conducted after a wide literature search on databases such as PubMed, Cochrane, and Google Scholar with keywords including \"Periodontitis,\" \"Respiratory,\" \"Infections,\" \"Tuberculosis,\" 'COVID-19', \"Pneumonia,\" \"Asthma,\" and \"COPD\" published in the last 15 years. The cornerstone of this comprehensive review lies in deciphering the pathogenesis and epidemiology of periodontitis and how these periodontal bacteria contribute to respiratory infections through numerous biological mechanisms, inflammatory pathways, and the potential pathways of infection transmission. We also explore the empirical evidence through research studies supporting the periodontitis-respiratory infections link and also studies with conflicting or inconclusive results. By connecting the dots between this crucial oral-systemic link, we hope to uncover the gaps in the current research and find new avenues for developing cost-effective, targeted, transformative preventive and therapeutic strategies that will not only improve oral health but will also support respiratory health and help reduce the global burden of respiratory infections. Strengthening oral hygiene programs could reduce the burden of respiratory diseases, particularly in elderly and high-risk populations.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2312-2324"},"PeriodicalIF":1.6,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959784/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Essentially crucial in early diagnosis and treatment of depression are the somatic symptoms, which can significantly decrease the morbidity and mortality associated with these symptoms and depression, as well as decrease the costs of investigation and treatment for the primary healthcare system. We conducted this study to determine the socio-demographic correlates of somatic symptoms in depression in a Pakistani population.
Methods: This cross-sectional study was conducted at the Department of Psychiatry, PIMS Hospital, Islamabad, during the period April 2025 to August 2025. A total of 243 male and female patients aged 12-60 years diagnosed with depression were enrolled. The patients were evaluated for somatic symptoms by conducting an interview based on the PHQ-15 questionnaire. Data was analyzed using SPSS v.26. The primary objective was to determine the prevalence of somatic symptom severity using PHQ-15 categories among patients with DSM-5-diagnosed depression. Secondary objectives were to examine associations between PHQ-15 severity and key sociodemographic predictors including age, gender, education, residence, and marital status.
Results: Gender wise distribution of the patients revealed that 74 males (30.5%) and 169 females (69.5%). In terms of age distribution, the largest age group was 12-25 years (n = 131, 53.9%), followed by 26-35 years (n = 63, 25.9%). Among the symptoms that bothered the patients a lot, low energy was most frequently reported by 144 patients (59.3%), followed by troubled sleeping by 117 (48.1%). Painful sexual intercourse was least commonly reported by 9 patients (3.7%). High PHQ-15 score was recorded in 52 patients (39.7%), aged 12-25 years, 26 (41.3%) patients aged 26-35 years, 12 (48.0%) patients aged 36-45 years, and 17 (70.8%) patients aged 46-60 years, respectively (P-value 0.011).
Conclusion: Most frequently reported somatic symptoms significantly bothering the patients were low energy and trouble sleeping. Age was significantly associated with the degree of somatization, and patients with advanced age were more frequently having a high degree of somatization.
{"title":"Frequency and correlates of somatic symptoms in patients of depression: a cross-sectional study at PIMS Islamabad.","authors":"Fatima Rizwan Bhatti, Remsha Tariq, Rida Hussain, Muddassir Khalid, Sumia Fatima, Laiba Fatima, Qamar Shoukat","doi":"10.1097/MS9.0000000000004804","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004804","url":null,"abstract":"<p><strong>Background: </strong>Essentially crucial in early diagnosis and treatment of depression are the somatic symptoms, which can significantly decrease the morbidity and mortality associated with these symptoms and depression, as well as decrease the costs of investigation and treatment for the primary healthcare system. We conducted this study to determine the socio-demographic correlates of somatic symptoms in depression in a Pakistani population.</p><p><strong>Methods: </strong>This cross-sectional study was conducted at the Department of Psychiatry, PIMS Hospital, Islamabad, during the period April 2025 to August 2025. A total of 243 male and female patients aged 12-60 years diagnosed with depression were enrolled. The patients were evaluated for somatic symptoms by conducting an interview based on the PHQ-15 questionnaire. Data was analyzed using SPSS v.26. The primary objective was to determine the prevalence of somatic symptom severity using PHQ-15 categories among patients with DSM-5-diagnosed depression. Secondary objectives were to examine associations between PHQ-15 severity and key sociodemographic predictors including age, gender, education, residence, and marital status.</p><p><strong>Results: </strong>Gender wise distribution of the patients revealed that 74 males (30.5%) and 169 females (69.5%). In terms of age distribution, the largest age group was 12-25 years (<i>n</i> = 131, 53.9%), followed by 26-35 years (<i>n</i> = 63, 25.9%). Among the symptoms that bothered the patients a lot, low energy was most frequently reported by 144 patients (59.3%), followed by troubled sleeping by 117 (48.1%). Painful sexual intercourse was least commonly reported by 9 patients (3.7%). High PHQ-15 score was recorded in 52 patients (39.7%), aged 12-25 years, 26 (41.3%) patients aged 26-35 years, 12 (48.0%) patients aged 36-45 years, and 17 (70.8%) patients aged 46-60 years, respectively (<i>P</i>-value 0.011).</p><p><strong>Conclusion: </strong>Most frequently reported somatic symptoms significantly bothering the patients were low energy and trouble sleeping. Age was significantly associated with the degree of somatization, and patients with advanced age were more frequently having a high degree of somatization.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2262-2268"},"PeriodicalIF":1.6,"publicationDate":"2026-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction and importance: Severe hypercalcemia typically produces QT interval shortening or ventricular arrhythmias, whereas bradyarrhythmias are exceptionally rare. The coexistence of hypercalcemia with acute kidney injury (AKI) - a condition that usually causes hypocalcemia - further underscores diagnostic complexity.
Case presentation: An 85-year-old man presented with AKI, confusion, and symptomatic sinus bradycardia (40 bpm) without atrioventricular block or QT prolongation. Laboratory studies showed markedly elevated corrected calcium, suppressed parathyroid hormone, and increased parathyroid hormone-related peptide. Chest CT revealed a 7 × 8 mm right-lung nodule. These findings are suggestive of humoral hypercalcemia of malignancy, although the etiology remains unconfirmed in the absence of tissue diagnosis. Treatment with intravenous hydration and zoledronic acid led to normalization of calcium, restoration of sinus rhythm (61 bpm), and improvement of renal function, obviating the need for pacing.
Discussion: This case is distinctive for demonstrating reversible sinus bradycardia in the setting of severe hypercalcemia and acute kidney injury - an atypical and physiologically unexpected combination. The biochemical profile raises suspicion for a paraneoplastic process, though this remains unconfirmed. The case underscores the importance of recognizing hypercalcemia as a reversible cause of bradyarrhythmia and considering malignancy in the appropriate clinical context when PTH is suppressed.
Conclusion: Hypercalcemia-induced bradycardia, though rare, is fully reversible with prompt metabolic correction. Awareness of this atypical presentation can prevent misdiagnosis, unnecessary pacemaker implantation, and delayed recognition of paraneoplastic disease.
{"title":"Sinus bradycardia as an atypical presentation of severe hypercalcemia: a case report and a literature review.","authors":"Besher Shami, Riyadh Saif, Iman Mousselli, Souhila Belhandouz, Hafsa Ashraf, Katherin Zambrano, Mostafa Helou, Kalpana Chilukuri, Pradeep Manoharan","doi":"10.1097/MS9.0000000000004802","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004802","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Severe hypercalcemia typically produces QT interval shortening or ventricular arrhythmias, whereas bradyarrhythmias are exceptionally rare. The coexistence of hypercalcemia with acute kidney injury (AKI) - a condition that usually causes hypocalcemia - further underscores diagnostic complexity.</p><p><strong>Case presentation: </strong>An 85-year-old man presented with AKI, confusion, and symptomatic sinus bradycardia (40 bpm) without atrioventricular block or QT prolongation. Laboratory studies showed markedly elevated corrected calcium, suppressed parathyroid hormone, and increased parathyroid hormone-related peptide. Chest CT revealed a 7 × 8 mm right-lung nodule. These findings are suggestive of humoral hypercalcemia of malignancy, although the etiology remains unconfirmed in the absence of tissue diagnosis. Treatment with intravenous hydration and zoledronic acid led to normalization of calcium, restoration of sinus rhythm (61 bpm), and improvement of renal function, obviating the need for pacing.</p><p><strong>Discussion: </strong>This case is distinctive for demonstrating reversible sinus bradycardia in the setting of severe hypercalcemia and acute kidney injury - an atypical and physiologically unexpected combination. The biochemical profile raises suspicion for a paraneoplastic process, though this remains unconfirmed. The case underscores the importance of recognizing hypercalcemia as a reversible cause of bradyarrhythmia and considering malignancy in the appropriate clinical context when PTH is suppressed.</p><p><strong>Conclusion: </strong>Hypercalcemia-induced bradycardia, though rare, is fully reversible with prompt metabolic correction. Awareness of this atypical presentation can prevent misdiagnosis, unnecessary pacemaker implantation, and delayed recognition of paraneoplastic disease.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2423-2429"},"PeriodicalIF":1.6,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959778/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction and importance: Parapharyngeal space (PPS) tumors are uncommon, accounting for 0.5%-1% of head and neck neoplasms. Diagnosis and treatment of parotid pleomorphic adenomas (PPA) extending to the PPS are difficult because the PPA is situated deep in the tissue.
Case presentation: A 49-year-old woman presented with a sore throat, odynophagia, and foreign body sensation in the throat for 6 weeks. Physical examination revealed a bulge in the oropharynx. Imaging revealed a clearly demarcated lesion in the right PPS of the neck. PPA diagnosis was confirmed using fine-needle aspiration cytology. Surgical removal of the tumor was performed via a transcervical transparotid approach with preservation of the facial nerve. Histopathological examination confirmed the diagnosis of pleomorphic adenoma, and the patient's symptoms were alleviated, with no recurrence at 8 months of follow-up.
Clinical discussion: The clinical onset is typically insidious and is characterized by a gradually enlarging mass in the parotid or upper neck, while oropharyngeal signs, such as dysphagia, snoring, dysphonia, or airway compromise, develop late in the course of the disease when the mass is sufficiently large or manifests as an intraoral bulge in the tonsillar or paratonsillar region.
Conclusion: This case highlights the importance of meticulous diagnosis using radiography and tailored surgical treatment for PPA in PPS. The transcervical transparotid approach enables tumor removal while preserving facial nerve function.
{"title":"Parapharyngeal parotid pleomorphic adenoma: a case report.","authors":"Omed Shafiq Hamaamin, Yadgar Abdulhameed Saeed, Ayoub Baqr Razha, Kosar Shirwan Tahir, Mohammed Kakabra Salih, Jeza Muhamad Abdul Aziz, Parshal Bhandari","doi":"10.1097/MS9.0000000000004778","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004778","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Parapharyngeal space (PPS) tumors are uncommon, accounting for 0.5%-1% of head and neck neoplasms. Diagnosis and treatment of parotid pleomorphic adenomas (PPA) extending to the PPS are difficult because the PPA is situated deep in the tissue.</p><p><strong>Case presentation: </strong>A 49-year-old woman presented with a sore throat, odynophagia, and foreign body sensation in the throat for 6 weeks. Physical examination revealed a bulge in the oropharynx. Imaging revealed a clearly demarcated lesion in the right PPS of the neck. PPA diagnosis was confirmed using fine-needle aspiration cytology. Surgical removal of the tumor was performed via a transcervical transparotid approach with preservation of the facial nerve. Histopathological examination confirmed the diagnosis of pleomorphic adenoma, and the patient's symptoms were alleviated, with no recurrence at 8 months of follow-up.</p><p><strong>Clinical discussion: </strong>The clinical onset is typically insidious and is characterized by a gradually enlarging mass in the parotid or upper neck, while oropharyngeal signs, such as dysphagia, snoring, dysphonia, or airway compromise, develop late in the course of the disease when the mass is sufficiently large or manifests as an intraoral bulge in the tonsillar or paratonsillar region.</p><p><strong>Conclusion: </strong>This case highlights the importance of meticulous diagnosis using radiography and tailored surgical treatment for PPA in PPS. The transcervical transparotid approach enables tumor removal while preserving facial nerve function.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2430-2433"},"PeriodicalIF":1.6,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959806/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-20eCollection Date: 2026-03-01DOI: 10.1097/MS9.0000000000004775
Mohsin Yahya Murshid, Esam Mohammad Murshid, Nedal Bukhari, Mohammad Alfayez, Tareq Salah, Yasir Bahadur
Obesity is a growing global health crisis with wide-ranging effects beyond metabolic and cardiovascular disorders. A substantial body of international evidence has linked excess adiposity to increased risk for various cancers. In Saudi Arabia, where obesity rates are among the highest globally, the relationship between obesity and cancer remains insufficiently characterized. This narrative review synthesizes global and regional literature on obesity-associated cancers, with a specific focus on the epidemiologic and research landscape in Saudi Arabia. A targeted search of PubMed, Google Scholar, and official databases from the World Health Organization, International Agency for Research on Cancer, and GLOBOCAN was conducted for English-language articles published between 1990 and 2023. The review highlights several cancers - postmenopausal breast, colorectal, liver, endometrial, kidney, and pancreatic - with convincing or probable associations with obesity. Alarmingly, many of these cancers also rank among the most common and fatal malignancies in Saudi Arabia, as shown in GLOBOCAN 2022 data. However, local research quantifying this link is limited. National cancer registries lack obesity-related variables, and longitudinal cohort studies are scarce. These gaps hinder the ability to implement evidence-based, obesity-targeted cancer prevention strategies. Given the convergence of high obesity prevalence and rising incidence of obesity-related cancers, urgent attention is needed to integrate obesity metrics into national cancer surveillance. Strategic investments in population-based cohort studies and registry reform are essential to inform tailored public health interventions and reduce the burden of obesity-related cancers in the Kingdom.
{"title":"The rising burden of obesity-linked cancers in Saudi Arabia: a public health review.","authors":"Mohsin Yahya Murshid, Esam Mohammad Murshid, Nedal Bukhari, Mohammad Alfayez, Tareq Salah, Yasir Bahadur","doi":"10.1097/MS9.0000000000004775","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004775","url":null,"abstract":"<p><p>Obesity is a growing global health crisis with wide-ranging effects beyond metabolic and cardiovascular disorders. A substantial body of international evidence has linked excess adiposity to increased risk for various cancers. In Saudi Arabia, where obesity rates are among the highest globally, the relationship between obesity and cancer remains insufficiently characterized. This narrative review synthesizes global and regional literature on obesity-associated cancers, with a specific focus on the epidemiologic and research landscape in Saudi Arabia. A targeted search of PubMed, Google Scholar, and official databases from the World Health Organization, International Agency for Research on Cancer, and GLOBOCAN was conducted for English-language articles published between 1990 and 2023. The review highlights several cancers - postmenopausal breast, colorectal, liver, endometrial, kidney, and pancreatic - with convincing or probable associations with obesity. Alarmingly, many of these cancers also rank among the most common and fatal malignancies in Saudi Arabia, as shown in GLOBOCAN 2022 data. However, local research quantifying this link is limited. National cancer registries lack obesity-related variables, and longitudinal cohort studies are scarce. These gaps hinder the ability to implement evidence-based, obesity-targeted cancer prevention strategies. Given the convergence of high obesity prevalence and rising incidence of obesity-related cancers, urgent attention is needed to integrate obesity metrics into national cancer surveillance. Strategic investments in population-based cohort studies and registry reform are essential to inform tailored public health interventions and reduce the burden of obesity-related cancers in the Kingdom.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2335-2347"},"PeriodicalIF":1.6,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-18eCollection Date: 2026-03-01DOI: 10.1097/MS9.0000000000004801
Hamza Sajid, Fatima Imran, Noor Un Nisa Irshad, Sakan Binte Imran
{"title":"YCT-529: a promising oral non-hormonal male contraceptive and its implications for family planning.","authors":"Hamza Sajid, Fatima Imran, Noor Un Nisa Irshad, Sakan Binte Imran","doi":"10.1097/MS9.0000000000004801","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004801","url":null,"abstract":"","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2460-2461"},"PeriodicalIF":1.6,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-18eCollection Date: 2026-03-01DOI: 10.1097/MS9.0000000000004793
Ayham Mousa, Laila Daas, Mohamad Nour Hababeh, Betoul Alhofari, Loujain Thalaj, Leen Al Erksoussi, Jana Abo Shukr, Leen Salman, Bilal Sleiay, Mouhammed Sleiay
Introduction and importance: Eosinophilic gastroenteritis (EGE) is a rare condition characterized by eosinophilic infiltration of the gastrointestinal tract, commonly presenting with abdominal pain, diarrhea, and peripheral eosinophilia. Corticosteroids are traditionally considered the mainstay of treatment.
Case presentation: A 45-year-old female presented with epigastric abdominal pain. Laboratory tests revealed marked peripheral eosinophilia, and upper endoscopy with biopsies confirmed mucosal-type EGE. The patient declined corticosteroid therapy and was commenced on montelukast 10 mg daily. She achieved complete symptom resolution within 2 weeks and maintained remission over a 12-month follow-up.
Clinical discussion: Corticosteroids remain the standard treatment for EGE, effectively reducing eosinophil counts and inflammatory mediators. In patients unable or unwilling to receive steroids, leukotriene receptor antagonists, such as montelukast, offer a viable alternative, demonstrating rapid symptom relief and potential for sustained remission.
Conclusion: Physicians should recognize EGE and its therapeutic complexities. Montelukast may serve as an effective corticosteroid-sparing strategy, enabling early symptom resolution and long-term remission.
{"title":"Eosinophilic gastroenteritis in a 45-year-old female with epigastric abdominal pain: a rare case report.","authors":"Ayham Mousa, Laila Daas, Mohamad Nour Hababeh, Betoul Alhofari, Loujain Thalaj, Leen Al Erksoussi, Jana Abo Shukr, Leen Salman, Bilal Sleiay, Mouhammed Sleiay","doi":"10.1097/MS9.0000000000004793","DOIUrl":"https://doi.org/10.1097/MS9.0000000000004793","url":null,"abstract":"<p><strong>Introduction and importance: </strong>Eosinophilic gastroenteritis (EGE) is a rare condition characterized by eosinophilic infiltration of the gastrointestinal tract, commonly presenting with abdominal pain, diarrhea, and peripheral eosinophilia. Corticosteroids are traditionally considered the mainstay of treatment.</p><p><strong>Case presentation: </strong>A 45-year-old female presented with epigastric abdominal pain. Laboratory tests revealed marked peripheral eosinophilia, and upper endoscopy with biopsies confirmed mucosal-type EGE. The patient declined corticosteroid therapy and was commenced on montelukast 10 mg daily. She achieved complete symptom resolution within 2 weeks and maintained remission over a 12-month follow-up.</p><p><strong>Clinical discussion: </strong>Corticosteroids remain the standard treatment for EGE, effectively reducing eosinophil counts and inflammatory mediators. In patients unable or unwilling to receive steroids, leukotriene receptor antagonists, such as montelukast, offer a viable alternative, demonstrating rapid symptom relief and potential for sustained remission.</p><p><strong>Conclusion: </strong>Physicians should recognize EGE and its therapeutic complexities. Montelukast may serve as an effective corticosteroid-sparing strategy, enabling early symptom resolution and long-term remission.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"88 3","pages":"2434-2437"},"PeriodicalIF":1.6,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12959758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147363967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}